Category: Approval/Launch Region: North America · United States Company: Ascletis Pharma Inc

Ascletis receives IND approval for its NASH drug

Ascletis receives IND approval for its NASH drug
Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!